Cargando…

Comprehensive characterization of RNA cargo of extracellular vesicles in breast cancer patients undergoing neoadjuvant chemotherapy

Extracellular vesicles (EVs) are g7aining increased attention as carriers of cancer-derived molecules for liquid biopsies. Here, we studied the dynamics of EV levels in the plasma of breast cancer (BC) patients undergoing neoadjuvant chemotherapy (NAC) and explored the relevance of their RNA cargo f...

Descripción completa

Detalles Bibliográficos
Autores principales: Sadovska, Lilite, Zayakin, Pawel, Eglītis, Kristaps, Endzeliņš, Edgars, Radoviča-Spalviņa, Ilze, Avotiņa, Elīza, Auders, Jānis, Keiša, Laura, Liepniece-Karele, Inta, Leja, Mārcis, Eglītis, Jānis, Linē, Aija
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644097/
https://www.ncbi.nlm.nih.gov/pubmed/36387168
http://dx.doi.org/10.3389/fonc.2022.1005812
_version_ 1784826673515986944
author Sadovska, Lilite
Zayakin, Pawel
Eglītis, Kristaps
Endzeliņš, Edgars
Radoviča-Spalviņa, Ilze
Avotiņa, Elīza
Auders, Jānis
Keiša, Laura
Liepniece-Karele, Inta
Leja, Mārcis
Eglītis, Jānis
Linē, Aija
author_facet Sadovska, Lilite
Zayakin, Pawel
Eglītis, Kristaps
Endzeliņš, Edgars
Radoviča-Spalviņa, Ilze
Avotiņa, Elīza
Auders, Jānis
Keiša, Laura
Liepniece-Karele, Inta
Leja, Mārcis
Eglītis, Jānis
Linē, Aija
author_sort Sadovska, Lilite
collection PubMed
description Extracellular vesicles (EVs) are g7aining increased attention as carriers of cancer-derived molecules for liquid biopsies. Here, we studied the dynamics of EV levels in the plasma of breast cancer (BC) patients undergoing neoadjuvant chemotherapy (NAC) and explored the relevance of their RNA cargo for the prediction of patients’ response to the therapy. EVs were isolated from serial blood samples collected at the time of diagnosis, at the end of NAC, and 7 days, 6, and 12 months after the surgery from 32 patients with locally advanced BC, and 30 cancer-free healthy controls (HCs) and quantified by nanoparticle tracking analysis. The pre-treatment levels of EVs in BC patients were higher than in HCs, significantly increased during the NAC and surgery, and decreased to the levels found in HCs 6 months after surgery, thus showing that a substantial fraction of plasma EVs in BC patients are produced due to the disease processes and treatment. RNA sequencing analysis revealed that the changes in the EV levels were associated with the alterations in the proportions of various RNA biotypes in EVs. To search for RNA biomarkers that predict response to the NAC, patients were dichotomized as responders and non-responders based on Miller-Payne grades and differential expression analyses were carried out between responders and non-responders, and HCs. This resulted in the identification of 6 miRNAs, 4 lncRNAs, and 1 snoRNA that had significantly higher levels in EVs from non-responders than responders at the time of diagnosis and throughout the NAC, and significantly lower levels in HCs, thus representing biomarkers for the prediction of response to NAC at the time of diagnosis. In addition, we found 14 RNAs representing piRNA, miRNA, lncRNA, snoRNA, and snRNA biotypes that were induced by NAC in non-responders and 2 snoRNAs and 1 piRNA that were induced by NAC in patients with early disease progression, thus warranting further functional studies on their role in chemoresistance and metastasis.
format Online
Article
Text
id pubmed-9644097
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96440972022-11-15 Comprehensive characterization of RNA cargo of extracellular vesicles in breast cancer patients undergoing neoadjuvant chemotherapy Sadovska, Lilite Zayakin, Pawel Eglītis, Kristaps Endzeliņš, Edgars Radoviča-Spalviņa, Ilze Avotiņa, Elīza Auders, Jānis Keiša, Laura Liepniece-Karele, Inta Leja, Mārcis Eglītis, Jānis Linē, Aija Front Oncol Oncology Extracellular vesicles (EVs) are g7aining increased attention as carriers of cancer-derived molecules for liquid biopsies. Here, we studied the dynamics of EV levels in the plasma of breast cancer (BC) patients undergoing neoadjuvant chemotherapy (NAC) and explored the relevance of their RNA cargo for the prediction of patients’ response to the therapy. EVs were isolated from serial blood samples collected at the time of diagnosis, at the end of NAC, and 7 days, 6, and 12 months after the surgery from 32 patients with locally advanced BC, and 30 cancer-free healthy controls (HCs) and quantified by nanoparticle tracking analysis. The pre-treatment levels of EVs in BC patients were higher than in HCs, significantly increased during the NAC and surgery, and decreased to the levels found in HCs 6 months after surgery, thus showing that a substantial fraction of plasma EVs in BC patients are produced due to the disease processes and treatment. RNA sequencing analysis revealed that the changes in the EV levels were associated with the alterations in the proportions of various RNA biotypes in EVs. To search for RNA biomarkers that predict response to the NAC, patients were dichotomized as responders and non-responders based on Miller-Payne grades and differential expression analyses were carried out between responders and non-responders, and HCs. This resulted in the identification of 6 miRNAs, 4 lncRNAs, and 1 snoRNA that had significantly higher levels in EVs from non-responders than responders at the time of diagnosis and throughout the NAC, and significantly lower levels in HCs, thus representing biomarkers for the prediction of response to NAC at the time of diagnosis. In addition, we found 14 RNAs representing piRNA, miRNA, lncRNA, snoRNA, and snRNA biotypes that were induced by NAC in non-responders and 2 snoRNAs and 1 piRNA that were induced by NAC in patients with early disease progression, thus warranting further functional studies on their role in chemoresistance and metastasis. Frontiers Media S.A. 2022-10-26 /pmc/articles/PMC9644097/ /pubmed/36387168 http://dx.doi.org/10.3389/fonc.2022.1005812 Text en Copyright © 2022 Sadovska, Zayakin, Eglītis, Endzeliņš, Radoviča-Spalviņa, Avotiņa, Auders, Keiša, Liepniece-Karele, Leja, Eglītis and Linē https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Sadovska, Lilite
Zayakin, Pawel
Eglītis, Kristaps
Endzeliņš, Edgars
Radoviča-Spalviņa, Ilze
Avotiņa, Elīza
Auders, Jānis
Keiša, Laura
Liepniece-Karele, Inta
Leja, Mārcis
Eglītis, Jānis
Linē, Aija
Comprehensive characterization of RNA cargo of extracellular vesicles in breast cancer patients undergoing neoadjuvant chemotherapy
title Comprehensive characterization of RNA cargo of extracellular vesicles in breast cancer patients undergoing neoadjuvant chemotherapy
title_full Comprehensive characterization of RNA cargo of extracellular vesicles in breast cancer patients undergoing neoadjuvant chemotherapy
title_fullStr Comprehensive characterization of RNA cargo of extracellular vesicles in breast cancer patients undergoing neoadjuvant chemotherapy
title_full_unstemmed Comprehensive characterization of RNA cargo of extracellular vesicles in breast cancer patients undergoing neoadjuvant chemotherapy
title_short Comprehensive characterization of RNA cargo of extracellular vesicles in breast cancer patients undergoing neoadjuvant chemotherapy
title_sort comprehensive characterization of rna cargo of extracellular vesicles in breast cancer patients undergoing neoadjuvant chemotherapy
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644097/
https://www.ncbi.nlm.nih.gov/pubmed/36387168
http://dx.doi.org/10.3389/fonc.2022.1005812
work_keys_str_mv AT sadovskalilite comprehensivecharacterizationofrnacargoofextracellularvesiclesinbreastcancerpatientsundergoingneoadjuvantchemotherapy
AT zayakinpawel comprehensivecharacterizationofrnacargoofextracellularvesiclesinbreastcancerpatientsundergoingneoadjuvantchemotherapy
AT eglitiskristaps comprehensivecharacterizationofrnacargoofextracellularvesiclesinbreastcancerpatientsundergoingneoadjuvantchemotherapy
AT endzelinsedgars comprehensivecharacterizationofrnacargoofextracellularvesiclesinbreastcancerpatientsundergoingneoadjuvantchemotherapy
AT radovicaspalvinailze comprehensivecharacterizationofrnacargoofextracellularvesiclesinbreastcancerpatientsundergoingneoadjuvantchemotherapy
AT avotinaeliza comprehensivecharacterizationofrnacargoofextracellularvesiclesinbreastcancerpatientsundergoingneoadjuvantchemotherapy
AT audersjanis comprehensivecharacterizationofrnacargoofextracellularvesiclesinbreastcancerpatientsundergoingneoadjuvantchemotherapy
AT keisalaura comprehensivecharacterizationofrnacargoofextracellularvesiclesinbreastcancerpatientsundergoingneoadjuvantchemotherapy
AT liepniecekareleinta comprehensivecharacterizationofrnacargoofextracellularvesiclesinbreastcancerpatientsundergoingneoadjuvantchemotherapy
AT lejamarcis comprehensivecharacterizationofrnacargoofextracellularvesiclesinbreastcancerpatientsundergoingneoadjuvantchemotherapy
AT eglitisjanis comprehensivecharacterizationofrnacargoofextracellularvesiclesinbreastcancerpatientsundergoingneoadjuvantchemotherapy
AT lineaija comprehensivecharacterizationofrnacargoofextracellularvesiclesinbreastcancerpatientsundergoingneoadjuvantchemotherapy